Allscripts and Sheba Medical Center Launch Partnership to Further Healthcare Innovation

AllscriptsAllscripts (NASDAQ: MDRX) and Israel's Sheba Medical Center have formed a partnership to accelerate the pace of artificial intelligence technologies and to improve patient care through the hospitals' ARC Innovation Center. ARC, which is an acronym for accelerate, redesign, and collaborate, is the innovation arm of Sheba Medical Center which has a vision to transform healthcare by 2030.

Sheba Medical Center, which currently uses the Allscripts dbMotion™ Solution for seamless interoperability and patient data harmonization, will host a lab space to promote innovation projects. Named by Newsweek as one of the top-ten hospitals in the world, the 2,000-bed hospital is the largest one in Israel, with state-of-the-art facilities located on a comprehensive, all-inclusive campus with a full range of medical divisions and specialties.

ARC Innovation brings new technologies into the hospital and community healthcare ecosystem to further improve patient care. It enables data fluidity and integration amongst innovators; scientists; startups; high-level developers; large and small companies; investors; and academia all under one roof. The organization focuses on digital health technologies, including precision medicine, big data and predictive analytics, telemedicine and mobile health. There are six medical tracks, with a senior Sheba physician leading each: telemedicine, precision medicine, digital innovation focusing on big data and artificial intelligence, augmented and virtual reality, rehabilitation and surgical innovation.

As part of this joint initiative, Allscripts' open system will be accessible in a space for researchers and developers, and ARC will serve as the platform for cooperation with Allscripts. In addition, Sheba Medical Center’s clinical and research staff and Israeli startups will assist by focusing on healthcare information technology. ARC and Allscripts will proactively seek out ideas and initiatives to enhance the development of new telemedicine and mobile solutions, including a future electronic health record encompassing home hospitalization medical information.

"Our partnership with Allscripts will provide a significant boost to startups and clinicians as they build new capabilities into Allscripts solutions through their unique Open platforms. With the need in rapid changes these days, we need a leader like Allscripts who's agile, open and connected to the needs of patients, clinicians and governments," stated Dr. Eyal Zimlichman, MD, MSc (MHCM), Deputy Director General, Chief Medical Officer and Chief Innovation Officer at Sheba Medical Center.

"Sheba Medical Center is an exemplar for successful healthcare delivery. Allscripts is proud to advance our partnership even further through the ARC initiative," said Paul M. Black, Allscripts Chief Executive Officer. "Creating an environment that encourages collaboration between some of the brightest minds in healthcare information technology speaks to our commitment to continuously innovate, capitalizing on our 13 year commitment to an Open platform, and our long standing belief to include the best minds to advance and best meet the needs of providers and patients across the globe."

About Allscripts

Allscripts (NASDAQ: MDRX) is a leader in healthcare information technology solutions that advance clinical, financial, and operational results. Our innovative solutions connect people, places and data across an Open, Connected Community of Health™. Connectivity empowers caregivers and consumers to make more informed decisions, delivering better care for healthier populations.

Most Popular Now

Open Call HORIZON-JU-IHI-2022-03-05: Dig…

Mental health disorders represent an area of severe unmet public health need. This has been further negatively impacted by the COVID-19 pandemic, with a substantial increase in the number and...

The Future of Medicine is Data

At the 2023 Annual J.P. Morgan Healthcare Conference, Owkin Co-founder and CEO Thomas Clozel, MD will outline how data is the future of medicine - from the development of new...

Brain Area Necessary for Fluid Intellige…

A team led by UCL and UCLH researchers have mapped the parts of the brain that support our ability to solve problems without prior experience - otherwise known as fluid...

Study Surveys Landscape of Apps Built on…

A study led by Regenstrief Institute Research Scientist Titus K. Schleyer, DMD, PhD, is among the first to survey the current landscape of FHIR® apps, providing a snapshot of how...

New Computer Program 'Learns' to Identif…

Genetic mutations cause hundreds of unsolved and untreatable disorders. Among them, DNA mutations in a small percentage of cells, called mosaic mutations, are extremely difficult to detect because they exist...

Applications Open for SpinLab Accelerato…

The start-up accelerator supports entrepreneurial and innovative teams that want to grow sustainably and successfully scale their business model. With a strong hands-on mentality and a lot of passion, the...

Allscripts Announces Corporate Name Chan…

Allscripts Healthcare Solutions, Inc. announced that, effective January 1, 2023, it has changed its name to Veradigm Inc. (NASDAQ: MDRX). Allscripts had been transitioning its solutions to the Veradigm brand...

Bayer to Accelerate Drug Discovery with …

Bayer AG and Google Cloud today announced a collaboration to drive early drug discovery that will apply Google Cloud's Tensor Processing Units (TPUs), which are custom-developed accelerators designed to run...

220M€ Investment in Testing and Experime…

To make the EU the place where AI excellence thrives from the lab to the market, the European Union is setting up world-class Testing and Experimentation Facilities (TEFs) for AI. Together...

Artificial Nerve Cells - Almost Like Bio…

Researchers at Linköping University (LiU), Sweden, have created an artificial organic neuron that closely mimics the characteristics of biological nerve cells. This artificial neuron can stimulate natural nerves, making it...

AI Tool Developed to Predict Risk of Lun…

Lung cancer is the leading cause of cancer death in the United States and around the world. Low-dose chest computed tomography (LDCT) is recommended to screen people between 50 and...

For Shared Decision-Making, Telemedicine…

Telemedicine may be just as effective as in-person visits when it comes to shared decision-making and communication for patients undergoing a first-time surgery consultation, according to a study published as...